ALVESCO 160mcg Price

Overview

Welcome to Dwaey, specifically on ALVESCO 160mcg Inhaler/Aerosol page.
This medicine contains an important and useful components, as it consists of Ciclesonide.
ALVESCO 160mcg is available in the market in concentration 160mcg/Puff and in the form of Inhaler/Aerosol.

NYCOMED GmbH is the producer of ALVESCO 160mcg and it is imported from GERMANY, The most popular alternatives of ALVESCO 160mcg are listed downward .

Mode Of Action

Ciclesonide, an inhaled corticosteriod, is converted by esterases in the lungs to the active metabolite, desisobutyryl-ciclesonide, which has anti-inflammatory activity.

Indication

• Asthma
• seasonal allergic rhinitis
• perennial allergic rhinitis

Precaution

Active or quiescent pulmonary TB, fungal, viral or bacterial infections, unless adequately treated. Severe hepatic impairment. Monitor height of children and adolescents on long term treatment with inhaled corticosteroids; reduce dose if growth is slow. Pregnancy, lactation. Ciclesonide nasal spray should be used with caution in patients with active or quiescent tuberculosis infection of the respiratory tract or in patients with untreated fungal, bacterial or systemic viral infections or ocular herpes simplex. Rare instances of nasal septal perforation, cataract, and glaucoma have been reported following intranasal application. Development of localized infections of the nose and pharynx with Candida albcans has rarely occurred. Although systemic effects have been minimal with recommended doses of Ciclesonide nasal spray, potential risk increases with larger doses. Therefore, larger than recommended doses of Ciclesonide nasal spray should be avoided. Lactation: Not known if excreted in breast milk, use caution

Side Effects

• Inhalation >10% Headache (11%)
• Nasopharyngitis (11%) 1-10% Epistaxis (4.9%)
• Ear pain (2.2%)
• Facial edema (3%)
• Urticaria (3%)
• Oral candidiasis (3%)
• Back pain (3%)
• Extremety pain (3%)
• Conjunctivitis (3%)
• Upper respiratory infection (9%)
• Gastroenteritis (3%)
• Sinusitis (3%) Nasal spray 1-10% Headache (3.1-6.6%)
• Epistaxis (2.9-6%)
• Nasopharyngitis (3.7%)
• Nasal discomfort (3.2%)
• Ear pain (2.2%)

Contra indication

Not for status asthmaticus or severe acute asthma where intensive measures are needed. Ciclesonide nasal spray is contraindicated in patients with a hypersensitivity to any of its ingredients.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks